Market Cap 26.06M
Revenue (ttm) 1.66M
Net Income (ttm) -34.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,069.28%
Debt to Equity Ratio 0.00
Volume 1,351,424
Avg Vol 5,568,396
Day's Range N/A - N/A
Shares Out 78.51M
Stochastic %K 52%
Beta 2.11
Analysts Sell
Price Target $4.00

Company Profile

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch...

Industry: Biotechnology
Sector: Healthcare
Phone: 678 270 3631
Fax: 678 270 4033
Address:
900 North Point Parkway, Suite 200, Alpharetta, United States
cheapwin
cheapwin Oct. 27 at 12:24 PM
0 · Reply
sushistocks23
sushistocks23 Oct. 26 at 12:05 AM
$CLSD Found a recent post about xipere. https://www.reddit.com/r/Ophthalmology/s/n5lV4HWXW9
0 · Reply
Dasmin
Dasmin Oct. 25 at 3:37 PM
$CLSD In our current state, how do we compare to VOR when they got their funding and ADVM when they got their CVR buyout?
1 · Reply
BaroloBuff
BaroloBuff Oct. 24 at 6:34 PM
I had a massive position in $ADVM, as I believe in their technology, but they didn’t have the funds nor the competent management to bring this to approval alone, nor to get their shareholders a fair deal. Hopefully $CLSD we’ll have better luck with the acquisition/partner, I’m much better terms for us. I haven’t been here for a while as well.
2 · Reply
maphere
maphere Oct. 24 at 3:24 PM
$CLSD Another GROK scenario below, but one thought to add is if RGNX / ABBV interested in CLSD acquiring now before BCRX readout would help reduce the risk of favorable results and rising CLSD price... GROK: Scenarios: Most Likely: $25-35/share (60% odds)—balances royalties (~$70M NPV) with risks (pause, HCR dilution). Unlikely Low (<$20): If fire-sale (e.g., delisting risk); <20% odds. Unlikely High (>$50): If multiple bidders (e.g., BioCryst adds); 20% odds. In conclusion, acquiring Clearside now lets REGENXBIO capture $50-100M+ in avoided royalties/milestones at a bargain ($20-30M cost), securing SCS for RGX-314's Phase 3 DR push—smart if AbbVie pushes for vertical integration. $20-$50/share is a realistic range for a deal, but watch Q3 earnings (late October) or filings for signals. No public interest yet, but the setup fits.
0 · Reply
BaroloBuff
BaroloBuff Oct. 24 at 2:31 PM
$ADVM time to move your money to the next eye biotech to be bought out $CLSD
2 · Reply
buyandsold
buyandsold Oct. 24 at 1:13 PM
$CLSD this stock is wide open for some shenanigans to screw the retail shareholders. We need a miracle!
0 · Reply
maphere
maphere Oct. 23 at 3:20 PM
$CLSD Vanguard Report (tute holding most clsd shares)... VTI ETF Daily Update, 10/23/2025 Currently, VTI’s five holdings with the highest upside potential are FibroBiologics FBLG -0.61% ▼ , Biodesix BDSX +8.67% ▲ , BioAtla BCAB +6.63% ▲ , Cibus CBUS +10.42% ▲ , and Clearside Biomedical CLSD +5.84% ▲ . https://www.tipranks.com/news/vti-etf-daily-update-10-23-2025
0 · Reply
Whales22
Whales22 Oct. 23 at 7:56 AM
How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $NXTT $SDOT $CLSD $BDSX Watchlist/
0 · Reply
Clifden
Clifden Oct. 23 at 4:20 AM
$CLSD Startin to think I should take the 70% hit and move on. Worst management in Bio since Maria at ANVS which I also took a much smaller shellacking !! 🤪
1 · Reply
Latest News on CLSD
Why Is Clearside Biomedical Stock Gaining Today?

Jun 25, 2024, 12:54 PM EDT - 1 year ago

Why Is Clearside Biomedical Stock Gaining Today?


cheapwin
cheapwin Oct. 27 at 12:24 PM
0 · Reply
sushistocks23
sushistocks23 Oct. 26 at 12:05 AM
$CLSD Found a recent post about xipere. https://www.reddit.com/r/Ophthalmology/s/n5lV4HWXW9
0 · Reply
Dasmin
Dasmin Oct. 25 at 3:37 PM
$CLSD In our current state, how do we compare to VOR when they got their funding and ADVM when they got their CVR buyout?
1 · Reply
BaroloBuff
BaroloBuff Oct. 24 at 6:34 PM
I had a massive position in $ADVM, as I believe in their technology, but they didn’t have the funds nor the competent management to bring this to approval alone, nor to get their shareholders a fair deal. Hopefully $CLSD we’ll have better luck with the acquisition/partner, I’m much better terms for us. I haven’t been here for a while as well.
2 · Reply
maphere
maphere Oct. 24 at 3:24 PM
$CLSD Another GROK scenario below, but one thought to add is if RGNX / ABBV interested in CLSD acquiring now before BCRX readout would help reduce the risk of favorable results and rising CLSD price... GROK: Scenarios: Most Likely: $25-35/share (60% odds)—balances royalties (~$70M NPV) with risks (pause, HCR dilution). Unlikely Low (<$20): If fire-sale (e.g., delisting risk); <20% odds. Unlikely High (>$50): If multiple bidders (e.g., BioCryst adds); 20% odds. In conclusion, acquiring Clearside now lets REGENXBIO capture $50-100M+ in avoided royalties/milestones at a bargain ($20-30M cost), securing SCS for RGX-314's Phase 3 DR push—smart if AbbVie pushes for vertical integration. $20-$50/share is a realistic range for a deal, but watch Q3 earnings (late October) or filings for signals. No public interest yet, but the setup fits.
0 · Reply
BaroloBuff
BaroloBuff Oct. 24 at 2:31 PM
$ADVM time to move your money to the next eye biotech to be bought out $CLSD
2 · Reply
buyandsold
buyandsold Oct. 24 at 1:13 PM
$CLSD this stock is wide open for some shenanigans to screw the retail shareholders. We need a miracle!
0 · Reply
maphere
maphere Oct. 23 at 3:20 PM
$CLSD Vanguard Report (tute holding most clsd shares)... VTI ETF Daily Update, 10/23/2025 Currently, VTI’s five holdings with the highest upside potential are FibroBiologics FBLG -0.61% ▼ , Biodesix BDSX +8.67% ▲ , BioAtla BCAB +6.63% ▲ , Cibus CBUS +10.42% ▲ , and Clearside Biomedical CLSD +5.84% ▲ . https://www.tipranks.com/news/vti-etf-daily-update-10-23-2025
0 · Reply
Whales22
Whales22 Oct. 23 at 7:56 AM
How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $NXTT $SDOT $CLSD $BDSX Watchlist/
0 · Reply
Clifden
Clifden Oct. 23 at 4:20 AM
$CLSD Startin to think I should take the 70% hit and move on. Worst management in Bio since Maria at ANVS which I also took a much smaller shellacking !! 🤪
1 · Reply
maphere
maphere Oct. 20 at 4:50 PM
$CLSD A new institutional add...I'll take it. Pre-split would equal around 350 K buy-in. https://www.nasdaq.com/market-activity/stocks/clsd/institutional-holdings
1 · Reply
Qora
Qora Oct. 19 at 6:04 PM
$CLSD would it have been better if George took the $2.5 buyout at the get go?
1 · Reply
maphere
maphere Oct. 17 at 9:32 PM
$CLSD $RGNX Here's the presentation slide deck presented today (23 slides) https://www.regenxbio.com/getmedia/7963aa56-bd54-47ae-afbb-9dffff943801/Wykoff_Sura-vec_SCS-ALTITUDE_AAO-2025_FINAL_v1b-12.pdf?ext=.pdf Slidedeck from Aug. 25th (13 slides) https://ir.regenxbio.com/static-files/ec4713fe-ca17-4e07-800b-0fd194153a8c
2 · Reply
DeppJones
DeppJones Oct. 17 at 8:18 PM
$CLSD Late breaking two year data update from RGNX's Altitude study (RGX-314 suprachoroidally) happening later today. https://ir.regenxbio.com/news-releases/news-release-details/regenxbio-announces-presentation-american-academy-ophthalmology @maphere
0 · Reply
cheapwin
cheapwin Oct. 16 at 7:12 PM
$CLSD phew... almost doubled down yesterday
0 · Reply
TwongStocks
TwongStocks Oct. 15 at 8:05 PM
One month post-RS recap. $BDSX 1:20 RS Sep 15, closed $7.60. Fell to its post-rs low $5.74 Sep 17. Rebounded to post-rs high of $8.61 Sep 24. A swing of 50% Sep 17-24. Today closed $7.42, down 2.37% from RS close. $CLSD 1:15 RS Sep 15, closed $3.95 Fell to post-rs low of $3.32 Sep 17. Hit its post-rs peak $4.50 Oct 6. A swing of 35.5% from Sep 17-Oct 6. Today closed $4.11, up 4.05% from RS close. $SDOT 1:10 RS Sep 15, closed $8.25 Was going downward since the RS. Hit a post-rs low of $5.00 Oct 13. However, it rebounded today. Hit $17.30 in premarket trading today. A swing of 246% from Oct 13-15. Today closed $7.72, down 6.42% from RS close.
0 · Reply
Del_Gue
Del_Gue Oct. 14 at 8:35 PM
$CLSD Anyone still here or do I need to turn off the light on my way out?
4 · Reply
buyandsold
buyandsold Oct. 10 at 7:40 PM
$CLSD i joined the fray today. What is the best DD write up?
0 · Reply
Clifden
Clifden Oct. 10 at 1:54 PM
$CLSD Management can’t even do this !! Pathetic at best
1 · Reply
cheapwin
cheapwin Oct. 10 at 1:45 PM
$CLSD 🚀🚀🚀 any day now
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 10:18 PM
Keep a close watch on CMCT! $CLSD $BDSX $STKH $DGNX _
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 8:37 PM
Keep a close watch on CMCT! $NXTT $SDOT $CLSD $BDSX 1
0 · Reply